288 related articles for article (PubMed ID: 30153640)
1. A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age.
Zhao X; Liu Q; Cao S; Pang J; Zhang H; Feng T; Deng Y; Yao J; Li H
J Affect Disord; 2018 Dec; 241():563-570. PubMed ID: 30153640
[TBL] [Abstract][Full Text] [Related]
2. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis.
Vlenterie R; van Gelder MMHJ; Anderson HR; Andersson L; Broekman BFP; Dubnov-Raz G; El Marroun H; Ferreira E; Fransson E; van der Heijden FMMA; Holzman CB; Kim JJ; Khashan AS; Kirkwood BR; Kuijpers HJH; Lahti-Pulkkinen M; Mason D; Misra D; Niemi M; Nordeng HME; Peacock JL; Pickett KE; Prady SL; Premji SS; Räikkönen K; Rubertsson C; Sahingoz M; Shaikh K; Silver RK; Slaughter-Acey J; Soremekun S; Stein DJ; Sundström-Poromaa I; Sutter-Dallay AL; Tiemeier H; Uguz F; Varela P; Vrijkotte TGM; Winterfeld U; Zar HJ; Zervas IM; Prins JB; Pop-Purceleanu M; Roeleveld N
Obstet Gynecol; 2021 Oct; 138(4):633-646. PubMed ID: 34623076
[TBL] [Abstract][Full Text] [Related]
5. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period.
Hwang YM; Roper RT; Piekos SN; Enquobahrie DA; Hebert MF; Paquette AG; Baloni P; Price ND; Hood L; Hadlock JJ
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2313364. PubMed ID: 38342572
[TBL] [Abstract][Full Text] [Related]
6. The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age.
Jensen HM; Grøn R; Lidegaard O; Pedersen LH; Andersen PK; Kessing LV
Psychopharmacology (Berl); 2013 Jul; 228(2):199-205. PubMed ID: 23455598
[TBL] [Abstract][Full Text] [Related]
7. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
8. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
9. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
[TBL] [Abstract][Full Text] [Related]
11. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
[TBL] [Abstract][Full Text] [Related]
12. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
[TBL] [Abstract][Full Text] [Related]
13. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.
Huang H; Coleman S; Bridge JA; Yonkers K; Katon W
Gen Hosp Psychiatry; 2014; 36(1):13-8. PubMed ID: 24094568
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
16. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
Malm H; Klaukka T; Neuvonen PJ
Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
[TBL] [Abstract][Full Text] [Related]
17. Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.
Molenaar NM; Brouwer ME; Bockting CL; Bonsel GJ; van der Veere CN; Torij HW; Hoogendijk WJ; Duvekot JJ; Burger H; Lambregtse-van den Berg MP
BMC Psychiatry; 2016 Mar; 16():72. PubMed ID: 26993629
[TBL] [Abstract][Full Text] [Related]
18. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors in pregnancy.
Bellissima V; Ververs TF; Visser GH; Gazzolo D
Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
[TBL] [Abstract][Full Text] [Related]
20. Safety of newer antidepressants in pregnancy.
Way CM
Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
